Cytoplasmic methionyl tRNA synthetase (MetRS) is one of more than 20 cytoplasmic aminoacyl tRNA synthetase enzymes (ARS). This family of enzymes catalyzes a process fundamental for protein translation. Using a combination of genetic mapping, oligonucleotide array comparative genomic hybridization, and phenotypic correlation, we show that mutations in the essential gene, let-65, reside within the predicted Caenorhabditis elegans homologue of MetRS, which we have named mars-1. We demonstrate that the lethality associated with alleles of let-65 is fully rescued by a transgenic array that spans the mars-1 genomic region. Furthermore, sequence analysis reveals that six let-65 alleles lead to the alteration of highly conserved amino acids.
Introduction
Analysis of mutations affecting genes that are essential for survival in model organisms, such as the nematode Caenorhabditis elegans, have been instrumental in developing our understanding of fundamental biological processes, for example cell division and morphology among others (Green et al., 2011) . Many of these processes have a direct relevance to the understanding of human diseases such as metabolic disorders and obesity (Hashmi et al., 2013) . The generation of mutations in essential genes and their correlation with a specific genetic locus is, therefore, the first step in understanding the nature of a gene's function in promoting survival. To more easily identify genes that are essential for survival in the model organism C. elegans, we created a physical deficiency map that encompasses a portion of Chromosome IV, allowing for the correlation Meta Gene 2 (2014) [819] [820] [821] [822] [823] [824] [825] [826] [827] [828] [829] [830] Nematode strains were cultured as previously described (Brenner, 1974) . Strains used in this study: N2 Bristol (BC00049), dpy-5(e907) (CB00907), let-65(s254); nT1(IV) (BC00962), let-65(s694); nT1(IV) (BC1121), let-65(s1154); nT1(IV) (BC2028), let-65(s1222); nT1(IV) (BC2116), let-65(s1083); nT1(IV) (BC1909), let-65(s1084); nT1(IV) (BC1910), let-65(s1730); nT1(IV) (BC3258), let-65(s1777); nT1(IV) (BC3305), let-65(s1083), unc-22(s7)(IV) [WRM0615dH10 + myo-2::GFP + pCeh361] (BC8656), let-65(s1222), unc-22(s7) (IV) [WRM0615dH10 + myo-2::GFP + pCeh361] (BC8696).
Oligonucleotide array comparative genomic hybridization (aCGH) data analysis aCGH experiments and analysis were performed as previously described (Jones et al., 2007) .
DNA sequence analysis
Genomic DNA was extracted from let-65 homozygous animals for eight alleles (s1730, s1083, s694, s1084, s254, s1154, s1777 and s1222) . PCR fragments spanning the mars-1 ORF were amplified from genomic DNA templates with primers designed using Primer 3 (Rozen and Skaletsky, 2000) (primer sequences available upon request). The amplified templates were subsequently sequenced (Macrogen, Korea) with appropriate sequencing primers (Supplementary Table 1 ).
Transgenic rescue
The fosmid WRM0615dH10, which spans the mars-1 genomic region (11,631,182 to 11,665 ,626 bp on LGIV), was injected into the syncytial gonads of dpy-5 (e907) animals at a final concentration of 3 ng/μl, along with the pharyngeal targeted green fluorescent protein (GFP) reporter myo-2::GFP at 10 ng/μl and the plasmid pCeh361,which contains wild-type dpy-5 that rescues the dpy-5 phenotype, at 100 ng/μl (Thacker et al., 2006) . Injected worms were plated (five P 0 s per plate) and phenotypically wild-type animals from the F 1 s generation that expressed the pharyngeal GFP reporter were individually isolated and propagated. GFP positive wild-type F 2 animals transmitting the transgenic array were selected and a PCR specific to the fosmid backbone performed to confirm the presence of the fosmid (Supplementary Table 1) . A single, stably transmitting, animal was selected to create transgenic lines. To conduct transgenic rescue experiments individual hermaphrodites carrying WRM0615dH10 + myo-2::GFP + pCeh361 were crossed to +/+ N2 males to obtain dpy-5 (e907)/+[WRM0615dH10 + myo-2::GFP + pCeh361] males. These GFP-expressing males were then crossed to let-65 (s1222); unc-22 (s7) and let-65 (s1803); unc-22 (s7) heterozygously maintained hermaphrodites. F 1 progeny were screened for the presence of males to ensure the cross was successful and F 1 wild-type hermaphrodites plated individually. F 2 animals were individually plated and screened for unconditional twitchers, which is indicative of viable homozygous animals of the genotype let-65 (s1083 or s1222) unc-22 (s7)/let-65 (s1083 or s1222) unc-22 (s7)(IV)[WRM0615dH10 + myo2::GFP + pCeh361]. Unconditional twitchers were individually plated and incubated at 20°C to assess rescue.
Microscopy
Screening of transgenic animals was performed using a Zeiss Axioscope (Quorum Technologies) set with a QImaging Camera and appropriate filter sets were used for GFP expression analysis. Animals were immobilized with 100 mM sodium azide (in water) immediately prior to imaging.
Bioinformatics studies
All reference DNA sequences were derived from WormBase release WS208. Analysis of sequence data and image processing were performed using BioEdit (http://www.mbio.ncsu.edu/BioEdit/BioEdit.html), WolFPSORT (Horton et al., 2007) (http://wolfpsort.org/), and BLASTP.
Results aCGH mapped deficiencies physically define seven zones in the unc-22 region of LGIV In an effort to characterize genes that are essential for survival in C. elegans we previously generated and mapped mutations that confer a lethal phenotype in the unc-22 region of the C. elegans genome (Rogalski et al., 1982) . The unc-22 region (from unc-43 to unc-31) represents approximately two map units (mu) on chromosome IV, which is spanned by 35 well-defined genetic deficiencies (Clark and Baillie, 1992; Clark et Marra and Baillie, 1994; Moerman and Baillie, 1981; Rogalski and Baillie, 1985; Rogalski et al., 1982; Schein et al., 1993) . Previously, genetic analysis was used to identify and position 31 lethal gene loci within this genetic deficiency map . However, because the precise molecular extent of the deficiencies was not known the construction of definitive candidate gene lists that corresponded to each mutated loci was not possible. To physically define the deficiency map in the unc-22 region we analyzed four of the most informative deficiencies using array comparative genomic hybridization (aCGH). aCGH is a method used to compare the DNA ratio between individual samples from the same organism in order to determine copy number variations on a chromosomal or genome-wide scale (Dhami et al., 2005) . This method can be used to determine the precise physical extent of genetic deficiencies in C. elegans (Jones et al., 2007) . In all four cases, array data was sufficient to position deficiency deletion breakpoints at a single-gene resolution to within approximately 6 kb (Table 1) . Deletion breakpoints fell either within single genes or between two genes. Using these data a seven-zone physical deficiency map was constructed spanning approximately 800 kb of the unc-22 region ( Fig. 1A and Table 1 ). Furthermore, by incorporating previously generated genetic mapping data for the molecularly unidentified lethal loci known to map into the region, we were able to assign each locus to a precisely defined list of candidate genes. The largest number of lethal loci map into zone two of the deficiency map (nine genes). Zone six contains seven lethal loci, while zones four and seven contain six lethal loci each. Zones one and five contain three lethal loci each. Finally, a single lethal locus was positioned into zone three (Fig. 1A ).
Sequence analysis of let-65 let-65 was the single lethal loci that mapped into zone three of the deficiency map (Fig. 1A) . Based on the physical extent of zone three only four annotated genes, F58B3.4, F58B3.5, F58B3.6 and F58B3.7 were candidates for let-65. let-65 is represented by nine alleles, all of which were isolated in EMS screens for larval lethality (Clark and Baillie, 1992; Rogalski and Baillie, 1985; Rogalski et al., 1982) . Since mutations in let-65 confer a lethal phenotype we correlated available RNAi data in order to rank the candidate genes based upon the severity of the reported RNAi phenotype Maeda et al., 2001; Piano et al., 2002; Simmer et al., 2003; Sonnichsen et al., 2005) (Fig. 1B) . Using this approach we identified F58B3.5 and F58B3.4 as the two strongest candidate genes. To identify mutations in F58B3.5 and F58B3.4 their genomic regions were amplified by PCR from let-65 (s254) homozygous animals and sequenced. A comparison of sequence data to the reference C. elegans genome (WormBase release WS208) revealed no mutations that were associated with F58B3.4. However, a point mutation was identified in the coding region of F58B3.5. This mutation resulted in a glutamic acid to lysine substitution (Glu364Lys) in a highly conserved amino acid ( Fig. 2 and Table 2 ). To provide additional confirmation that mutation of F58B3.5 was associated with let-65 we sequenced the F58B3.5 ORF in the remaining let-65 alleles, detecting the presence of additional mutations in seven of the eight alleles tested. All mutations identified were G → C to A → T transitions, consistent with the known mutational spectrum for ethane methylsulfonate (EMS) mutagenesis (Fig. 2, Table 2 ) (Maple and Moller, 2007) . In every case, with the exception of s1777 and s1222, the identified mutations were substitutions in highly conserved amino acids in the predicted MetRS domain of F58B3.5 (Figs. 1C and 2) . The lesion s1777 resulted in a 508 amino acid truncation, while s1222 contained a mutation in the first base of the first intron. s1222 potentially prevents splicing of the first intron, which would result in a premature truncation of the protein at amino acid 28 (Fig. 1C) . Together these data demonstrate that let-65 and F58B3.5 represent the same gene. F58B3.5 encodes a cytoplasmic Class I synthetase, methionyl tRNA synthetase (MetRS) that is evolutionary well conserved, with 58% identity and 71% similarity to its human homologue (BlastP alignment Altschul et al., 1997 Altschul et al., , 2005 (Fig. 2) . We have renamed F58B3.5 mars-1 (Methionyl Amino-acyl tRNA Synthetase-1).
Rescue of let-65 with a fosmid containing mars-1
We have shown that mutations of mars-1 are present in let-65 animals. To provide further evidence that these mutations caused the lethality associated with let-65, we performed transgenic rescue experiments. The fosmid clone WRM0615dH10 spans the entire mars-1 genomic region, but excludes the F58B3.4 ORF (Fig. 1B) . We found that transgenic animals carrying WRM0615dH10 as an extra-chromosomal array successfully and specifically rescued the lethality associated with the two alleles of let-65 tested (s1083 and s1222). Furthermore these transgenic animals were superficially wild type in appearance except for the twitching phenotype due to the presence of the unc-22 (s7) homozygous mutation, which was used as a visible phenotypic marker. Individual viable animals were isolated to start the strains BC8656 and BC8696 for alleles s1083 and s1222 respectively, and cultured over multiple generations to confirm continued rescue of the lethal phenotype. Together the sequence and rescue data confirm that mutation of mars-1 gives rise to the lethal phenotype in let-65 animals.
Mitochondrial methionyl tRNA synthetase candidate MARS-1 has been predicted to encode the cytoplasmic form of MetRS (Havrylenko et al., 2010) . Computational analysis of the predicted MARS-1 protein (WormBase WS209) demonstrated that mars-1 encodes a protein that localizes subcellularly in the cytoplasm. BLASTP analysis of Y105E8A.20 (Altschul et al., 1997) , a second gene predicted to encode methionyl tRNA synthetase in C. elegans (WormBase WS211), implies mitochondrial localization for the encoded protein.
Discussion
In this study we used aCGH to define a physical deficiency map for a 2 Mb portion of LGIV in C. elegans. Using this deficiency map we correlated physical candidate gene lists with mutations in a number of previously identified essential genes (Clark, 1990; Clark and Lyckegaard, 1988; Moerman, 1980; Rogalski and Baillie, 1985; Rogalski et al., 1982) . From our analysis we were able to determine that the genetically identified locus let-65 corresponds to mars-1, which encodes the C. elegans homologue of MetRS. let-65 is one of a number of lethal genes previously identified in EMS screens for essential genes on the right end of LGIV. These screens generated seven alleles for let-65 six of which resulted in lethality (s253, s1777, s1083, s1154, s1222 and s1730), and one additional allele causing sterility (s694). Previously it has been reported that inactivation of MARS-1 by RNAi leads to embryonic lethality Sonnichsen et al., 2005) . Moreover, this loss of MARS-1 function can also lead to sterility (Havrylenko et al., 2011) . Furthermore, correlation of available phenotypic information for other ARS family members deleted by targeted mutations demonstrates a complete correlation of lethal and sterile phenotypes, highlighting the essential nature of this family of enzymes (Table 3) . Together these data indicate that mars-1 is essential for processes that require large scale protein biosynthesis, such as embryogenesis (Havrylenko et al., 2011) .
In C. elegans cytoplasmic MetRS (MARS-1) is a 917 amino acid protein that has multiple predicted functional domains. The minimal core enzyme, as found in the bacteria Aquifex aeolicus, consists of a core catalytic domain (CAT), which is distinguished by a Rossmann fold that is a characteristic domain of Class I aminoacyl tRNA synthetase enzymes (catalyzes the aminoacylation reaction), and an anticodon-binding domain (ABD) (promotes tRNA-protein association) (Nakanishi et al., 2005) . Additional domains, found in eukaryotes, are appended in front of or after the core domain of the enzyme and are believed to increase the stability of tRNA-protein complexes (Havrylenko et al., 2010) . In humans, MARS carries a C-terminal domain that causes a slow release of aminoacyl-tRNA and provides the aminoacylation reaction with a limiting step (Havrylenko et al., 2010) . In C. elegans, the MARS-1 protein model contains a t-RNA binding domain (tRBD) of about 170 Table 2 Mutations identified in let-65 by sequencing and BioEdit analysis.
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Nucleotide change Codon mutation Amino acid change
residues appended in cis at the C-terminus of the enzyme, which is homologous to the tRBD domain appended at the C-terminus of MetRS in Oriza sativa (rice) (Havrylenko et al., 2010) . However, in C. elegans, this domain is separated from the ABD domain by a putative protein-binding domain of approximately 150 residues (Havrylenko et al., 2010) . This domain is similar to the human P43 protein, which is a non-synthetase component of the aminoacyl tRNA synthetase complex required for the assembly of the protein within the complex (Havrylenko et al., 2011) . The predicted C. elegans MARS-1 catalytic core domain comprises amino acids 36 to 407 (Marchler-Bauer et al., 2009 ). In let-65 six out of the eight mutations reside in this domain (s1730, s1083, s694, s1084, s254 and s1154) suggesting that they disrupt the function of the catalytic core. The EMS induced mutation in let-65(s1777) creates a truncated protein that lacks the anticodon-binding domain (AA416 to AA545) (Marchler-Bauer et al., 2009 ) and the tRNA binding domain (AA755 to AA857) (Marchler-Bauer et al., 2009) . let-65(s1222) contains a mutation in the first base of the first intron putatively preventing splicing of the first intron resulting in putative premature truncation at amino acid 28. mars-1 is highly conserved and encodes a protein with unique significance for translational control. Structures of MARS-1 from Escherichia coli (Mechulam et al., 1999) and Thermus thermophiles (Sugiura et al., 2000) have been reported. MARS-1 from E. coli has greater identity than T. thermophiles to the protein in C. elegans. Amino acids altered in four of the six C. elegans missense mutations are located in conserved regions in both E. coli and T. thermophiles: let-65(s1083): βC; let-65(s694): turn between β2 and β3 (zinc-binding domain); let-65(s254): turn between β7 and α6; let-65(s1154): turn between α7 and β8. let-65(s1730) is in turn between βA and αA and let-65(s1084) is in turn between β5 and β6. All identified let-65 changes are located in E. coli at the Rossman-like fold. emb; lvl; ste yars-1 emb; lvl; ste emb = embryonic lethality, lvl = larval lethality, let = lethal, ste = sterile, ND = not determined.
let-65(s1777) contains a nonsense mutation wherein the tryptophan codon at amino acid 408 becomes an amber stop codon. let-65(s1222) has a mutation that putatively prevents splicing of the first intron resulting in premature truncation, the truncated protein lacks the majority of the synthetase including the catalytic domain, the two binding domains, the anticodon-binding domain, and the tRNA binding domain. s1777 and s1222 are, therefore, both putatively null alleles. The phenotypes (mid-larval arrest) (Clark and Baillie, 1992; of these two mutants are indistinguishable from six other let-65 alleles. Based on this observation we predict that all six alleles are null for MARS-1 function, or reduce MARS-1 activity below a threshold required for survival. Moreover, the survival of nematodes, containing those alleles to mid-larva, suggests that for the early developmental stages, the mother supplies MARS-1 to eggs during oogenesis.
let-65(s694) and let-65(s1083) contain mutations that change glycine to glutamic acid at amino acids 186 and 126 respectively. These two amino acids are in sequence blocks that are conserved from human to yeast. let-65(s1084) contains a mutation that changes glycine to arginine at amino acid 275. Generally, a change from a small non-charged non-hydrophilic glycine to a large positively charged hydrophilic arginine could disrupt the structure of a protein enough to render it non-functional, which in the case of let-65 would cause lethality. let-65 (s1730) contains a mutation that changes alanine to valine at position 41. In humans, Drosophila melanogaster and Saccharomyces cerevisiae, a serine codon is located at the same position within a highly conserved sequence block. Because a change from a polar amino acid (serine) to a non-polar amino acid (valine) could disrupt the protein's structure more than replacing alanine with valine we analyzed the available sequences to confirm the C. elegans wild type reference sequence at position 41. After analyzing the same sequence stretch in the other let-65 alleles we concluded definitively that an alanine is present at position 41. The mutation in let-65(s254) replaces a conserved acidic amino acid (glutamic acid) with a basic amino acid (lysine) at position 364. This position is within the catalytic domain of MARS-1. let-65(s1154) has a polar amino acid (proline) instead of the non-polar amino acid (leucine) at position 400 that is within the catalytic domain. Additionally, since alterations of proline in the flanking regions of active sites are known to change the activity of the protein (Proline bracket hypothesis) (Kini et al., 1998) , this mutation may exhibit drastic effects on MARS-1 activity.
Typically, eukaryotic cells have two forms of ARS: cytoplasmic and mitochondrial (Walker et al., 1983) . MARS-1 localizes to the cytoplasm (Havrylenko et al., 2010) . Therefore, we attempted to find the candidate gene coding for the mitochondrial form of the enzyme. The C. elegans genome contains a second ORF, Y105E8A.20 that is predicted to encode a methionyl tRNA synthetase (WormBase WS211). Y105E8A.20 is a 1221 bp gene that encodes a 406 amino acid protein. BlastP was used to search the Swiss-Prot database with MARS-1 amino acid sequences as queries (Altschul et al., 1997 (Altschul et al., , 2005 . In the BlastP searches S. cerevisiae was used as the canonical genome to identify protein localizations in C. elegans. S. cerevisiae was used because it's one of the simplest in regard to identifying open reading frames (ORFs), and it is the most highly characterized eukaryotic genome (Fisk et al., 2006) . BlastP localization, based on S. cerevisiae matches, predicted mitochondrial localization for the protein encoded by Y105E8A.20.
The C. elegans million mutations project (MMP) comprises a library of 2007 mutagenized and homozygous C. elegans strains that were sequenced to identify the resulting mutations. The aim of this project was to generate mutant alleles in each gene in the C. elegans genome. However, a limitation of this approach is that severely detrimental mutations in genes required for viability would be selected against since these strains must be viable and fertile. Of the 14 MMP mutations that are recorded for mars-1, all are missense mutations with the single exception of a mutation that is predicted to affect splicing of an intron in the C-terminus of the protein. This intron is not conserved in other species (Table 4) . Out of the remaining 13 alleles 10 affect residues that are also not conserved. Interestingly three mutations reside within the catalytic core of the enzyme. Since these strains are viable it is, however, unlikely that these lesions severely affect the function of the protein. Alternatively secondary mutations within these strains might be present that could compensate for any detrimental effect on enzyme function. Further studies would be required to ascertain if this is the case.
In our study we isolated and identified eight mars-1 alleles all of which lead to a loss-of-function phenotype. Furthermore, the number of alleles isolated in mars-1 is greater than the average number of alleles isolated for most genes in screens of this type (Berg et al., 2001; Brenner, 1974; Deniziak and Barciszewski, 2001; Horton et al., 2007; Jones et al., 2007; Rozen and Skaletsky, 2000; Thacker et al., 2006) . This indicates that let-65 (mars-1) is a large mutagenic target for EMS. The availability of the loss of function alleles allows for further exploration of the gene's structure and function in a tractable model system. Moreover, it will facilitate a better understanding of ARS, which will lead to a deeper understanding of the complete protein synthesis machinery in all organisms including humans.
Supplementary data to this article can be found online at http://dx. 
